Bain Capital, LP is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact

Chris Gordon

Chris Gordon

Private Equity

Focus Area


Chris Gordon joined Bain Capital in 1997. He is a Partner, Co-Head of Global Private Equity, Co-Head of Bain Capital’s North America Private Equity business, and Global Head of Healthcare.

Since joining the firm, Mr. Gordon has actively served on the Board of Directors for a wide spectrum of prominent healthcare companies in which Bain Capital has made investments including HCA, Quintiles Transnational (now IQVIA), Grupo Notre Dame Intermedica, Air Medical Group Holdings, Acadia, Beacon Health Options, Physio Control, QuVa Pharamceuticals, Waystar, Aveanna, Surgery Partners, Stada GMBH, US Renal Care, and Cerevel Therapeutics.

Prior to joining Bain Capital, Mr. Gordon was a consultant at Bain & Company.  He is a founding Director of the Healthcare Private Equity Association and is engaged with numerous nonprofit organizations.  He is also a member of the Council on Foreign Relations.


Mr. Gordon received an A.B. in Economics from Harvard College graduating magna cum laude and an M.B.A. from Harvard Business School where he was a Baker Scholar.